LFWD
Lifeward·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LFWD
Lifeward Ltd.
A supplier of exoskeleton medical equipment
Healthcare Equipment and Supplies
06/20/2001
09/12/2014
NASDAQ Stock Exchange
80
12-31
Common stock
200 Donald Lynch Blvd., Marlborough, MA 01752
--
Lifeward Ltd., was established in Israel on June 20, 2001. The company is an innovative medical device company that designs, develops and commercializes skeletons that enable people with reduced mobility in wheelchairs or other medical conditions to have the ability to fight and walk again. The company has developed and continues to commercialize ReWalk, an exoskeleton that uses the company's patented technology and tilt sensors, onboard computers, sensors and motion sensors to drive the power of electric leg movement.
Earnings Call
Company Financials
EPS
LFWD has released its 2025 Q3 earnings. EPS was reported at -0.19, versus the expected -0.18, missing expectations. The chart below visualizes how LFWD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LFWD has released its 2025 Q3 earnings report, with revenue of 6.20M, reflecting a YoY change of 1.09%, and net profit of -3.17M, showing a YoY change of -2.79%. The Sankey diagram below clearly presents LFWD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


